Vimarsana
Biggest News Aggregation in the World

Page 21 - Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program Updates Today - Breaking & Trending Today

Co. Drills To Expand Resource at Ni-PGE Project in U.S. - Vimarsana News

Co. Drills To Expand Resource at Ni-PGE Project in U.S.

Co. Drills To Expand Resource at Ni-PGE Project in U.S.

Inverness to decide final millage rate, budget - Vimarsana News

Inverness to decide final millage rate, budget

Inverness City Council members will be setting the final millage rate and budget adoption for Fiscal Year 2023-24 when it convenes at 5:30 p.m. Tuesday, Sept. 19.

Silence Therapeutics Reports Second Quarter 2023 Results - Vimarsana News

Silence Therapeutics Reports Second Quarter 2023 Results

Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,... -Today at 07:03 am- MarketScreener

Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update

NDA submission for etripamil in patients with PSVT expected in October 2023Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with... -Today at 07:37 am- MarketScreener

Veru Reports Fiscal 2023 Third Quarter Financial Results - Vimarsana News

Veru Reports Fiscal 2023 Third Quarter Financial Results

Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm +/- abemaciclib accelerated approval pathway in metastatic breast cancer, if successful based... -Today at 06:31 am- MarketScreener